WO1998021355A1
(en)
|
1996-11-15 |
1998-05-22 |
Life Technologies, Inc. |
Mutants of green fluorescent protein
|
US6602677B1
(en)
*
|
1997-09-19 |
2003-08-05 |
Promega Corporation |
Thermostable luciferases and methods of production
|
AU765703B2
(en)
*
|
1998-03-27 |
2003-09-25 |
Bruce J. Bryan |
Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
|
EP1925320A3
(en)
*
|
1998-03-27 |
2008-09-03 |
Prolume, Ltd. |
Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics
|
US7090976B2
(en)
*
|
1999-11-10 |
2006-08-15 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions comprising Renilla GFP
|
JP2002524087A
(ja)
*
|
1998-09-03 |
2002-08-06 |
ローマ リンダ ユニバーシティー |
インビボにおいてタンパク質相互作用を調べる方法
|
US9834584B2
(en)
*
|
1998-12-11 |
2017-12-05 |
Takara Bio Usa, Inc. |
Nucleic acids encoding chromophores/fluorophores and methods for using the same
|
US20030087492A1
(en)
|
2001-11-02 |
2003-05-08 |
Promos Technologies, Inc. |
Semiconductor device and method of manufacturing the same
|
US7338783B2
(en)
|
1998-12-11 |
2008-03-04 |
Clontech Laboratories, Inc. |
Nucleic acids encoding chromophores/fluorophores and methods for using the same
|
FI107167B
(fi)
*
|
1999-06-07 |
2001-06-15 |
Marko Virta |
Menetelmä mikro-organismin kasvun ja kuolemisen määrittämiseksi
|
US6716614B1
(en)
*
|
1999-09-02 |
2004-04-06 |
Lexicon Genetics Incorporated |
Human calcium dependent proteases, polynucleotides encoding the same, and uses thereof
|
US6541252B1
(en)
|
2000-05-19 |
2003-04-01 |
Lexicon Genetics Incorporated |
Human kinases and polynucleotides encoding the same
|
EP1305412A2
(en)
*
|
1999-10-14 |
2003-05-02 |
Clontech Laboratories Inc. |
Anthozoa derived chromo/fluoroproteins and methods for using the same
|
WO2001046694A2
(en)
*
|
1999-12-22 |
2001-06-28 |
Biosignal Packard Inc. |
A bioluminescence resonance energy transfer (bret) fusion molecule and method of use
|
DE60026603T2
(de)
*
|
1999-12-22 |
2007-03-01 |
PerkinElmer BioSignal Inc., Montréal |
Biolumineszenz-Resonanz-Energie-Transfer(BRET)-System mit großer spektraler Auflösung zwischen der Donator- und der Akzeptoremissionswellenlänge sowie dessen Verwendun
|
US6502774B1
(en)
*
|
2000-03-08 |
2003-01-07 |
J + L Fiber Services, Inc. |
Refiner disk sensor and sensor refiner disk
|
AU2001247445B2
(en)
*
|
2000-03-15 |
2006-09-21 |
Gaussia L.L.C. |
Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
|
US20030224415A1
(en)
*
|
2001-06-29 |
2003-12-04 |
Gala Design, Inc. |
Selection free growth of host cells containing multiple integrating vectors
|
AU2001271614B2
(en)
*
|
2000-07-03 |
2007-05-31 |
Catalent Pharma Solutions, Llc |
Host cells containing multiple integrating vectors
|
AU2001270252B2
(en)
*
|
2000-07-03 |
2007-02-08 |
Catalent Pharma Solutions, Llc |
Expression vectors
|
US6890745B1
(en)
|
2000-07-19 |
2005-05-10 |
Chemicon International, Inc. |
Protease specific cleavable luciferases and methods of use thereof
|
US7879540B1
(en)
*
|
2000-08-24 |
2011-02-01 |
Promega Corporation |
Synthetic nucleic acid molecule compositions and methods of preparation
|
US20030157643A1
(en)
*
|
2000-08-24 |
2003-08-21 |
Almond Brian D |
Synthetic nucleic acids from aquatic species
|
JP2004508042A
(ja)
*
|
2000-09-07 |
2004-03-18 |
オウマン,クリスター,エス.,オー. |
細胞表面受容体−リガンド結合のためのレポーターシステム
|
ATE337336T1
(de)
*
|
2000-10-12 |
2006-09-15 |
Clontech Lab Inc |
Nukleinsäuren, die für stichodactylidae chromoproteine kodieren
|
EP1409674A2
(en)
*
|
2000-10-27 |
2004-04-21 |
Lexicon Genetics Incorporated |
Human 7tm proteins and polynucleotides encoding them
|
US7060442B2
(en)
*
|
2000-10-30 |
2006-06-13 |
Regents Of The University Of Michigan |
Modulators on Nod2 signaling
|
WO2002036633A2
(en)
*
|
2000-10-30 |
2002-05-10 |
Lexicon Genetics Incorporated |
Human 7tm proteins and polynucleotides encoding the same
|
ATE351902T1
(de)
*
|
2000-11-03 |
2007-02-15 |
Univ Michigan |
Oberflächentransfektion und expressionsverfahren
|
US6897067B2
(en)
*
|
2000-11-03 |
2005-05-24 |
Regents Of The University Of Michigan |
Surface transfection and expression procedure
|
US6902933B2
(en)
*
|
2000-11-03 |
2005-06-07 |
Regents Of The University Of Michigan |
Surface transfection and expression procedure
|
US7279317B2
(en)
*
|
2001-01-12 |
2007-10-09 |
California Institute Of Technology |
Modulation of COP9 signalsome isopeptidase activity
|
EP1349922A4
(en)
*
|
2001-01-12 |
2005-09-07 |
California Inst Of Techn |
REGULATING THE ACTIVITY OF A TARGET PROTEIN THROUGH MODIFIED PROTEINS
|
US6969597B2
(en)
*
|
2001-02-21 |
2005-11-29 |
Clontech Laboratories, Inc. |
Nucleic acids encoding non aggregating fluorescent proteins and methods for using the same
|
US6849449B2
(en)
*
|
2001-03-01 |
2005-02-01 |
Regents Of The University Of Michigan |
Orphanin FQ receptor nucleic acids
|
NZ528166A
(en)
*
|
2001-03-02 |
2007-05-31 |
Stratatech Corp |
A method for preparing a seeded dermal equivalent
|
JP3929250B2
(ja)
*
|
2001-03-08 |
2007-06-13 |
株式会社ルネサステクノロジ |
半導体装置
|
US7294511B2
(en)
|
2001-03-22 |
2007-11-13 |
Chromos Molecular Systems, Inc. |
Methods for delivering nucleic acid molecules into cells and assessment thereof
|
US20030186390A1
(en)
*
|
2001-03-22 |
2003-10-02 |
De Jong Gary |
Methods for delivering nucleic acid molecules into cells and assessment thereof
|
US6936469B2
(en)
|
2001-03-22 |
2005-08-30 |
Chromos Molecular Systems Inc. |
Methods for delivering nucleic acid molecules into cells and assessment thereof
|
EP1262553A1
(en)
*
|
2001-05-22 |
2002-12-04 |
ADEREGEM (Association pour le Développement de la Recherche en Génétique Moléculaire |
Luciferase-selection marker fusion proteins, polynucleotides encoding such proteins, and uses thereof
|
WO2002096924A1
(en)
*
|
2001-05-25 |
2002-12-05 |
Clontech Laboratories, Inc. |
Kindling fluorescent proteins and methods for their use
|
JP3829252B2
(ja)
|
2001-06-08 |
2006-10-04 |
独立行政法人理化学研究所 |
蛍光蛋白質
|
WO2003008435A2
(en)
*
|
2001-07-06 |
2003-01-30 |
Board Of Trustees Of The University Of Illinois |
Gfp fusion proteins and their use
|
US7393656B2
(en)
|
2001-07-10 |
2008-07-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for risk stratification
|
EP1281767A3
(en)
|
2001-07-31 |
2003-05-28 |
Aladar A. Szalay |
Light emitting microorganisms and cells for diagnosis and therapy of tumors
|
EP1434483B1
(en)
*
|
2001-10-12 |
2007-12-05 |
Clontech Laboratories, Inc. |
Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same
|
WO2003033650A2
(en)
*
|
2001-10-15 |
2003-04-24 |
Stratagene |
Recombinant renilla reniformis system for bioluminescence resonance energy transfer
|
EP1444245A4
(en)
*
|
2001-11-13 |
2005-11-16 |
Clontech Lab Inc |
NEW CHROMOPHORE / FLUOROPHORE AND METHOD FOR THE APPLICATION
|
CA2467383C
(en)
*
|
2001-12-19 |
2012-08-28 |
The University Of Chicago |
Rapidly maturing fluorescent proteins and methods for using the same
|
JP2005514032A
(ja)
*
|
2001-12-26 |
2005-05-19 |
クローンテック ラボラトリーズ インク. |
変異体発色団/蛍光団ならびにそれらの製造法および使用法
|
US6918839B2
(en)
*
|
2002-01-28 |
2005-07-19 |
The Boeing Company |
Damage tolerant shaft
|
US7255986B2
(en)
*
|
2002-01-31 |
2007-08-14 |
The Board Of Trustees Operating Michigan State University |
Compositions for the diagnosis and treatment of epizootic catarrhal enteritis in ferrets
|
EP1485492B1
(en)
|
2002-03-19 |
2011-12-21 |
Stichting Dienst Landbouwkundig Onderzoek |
Gntiii (udp-n-acetylglucosamine:beta-d mannoside beta(1,4)-n-acetylglucosaminyltransferase iii) expression in plants
|
US20040038304A1
(en)
*
|
2002-03-28 |
2004-02-26 |
Gala Design, Inc. |
Antibody libraries
|
US7384738B2
(en)
*
|
2002-03-28 |
2008-06-10 |
Bremel Robert D |
Retrovirus-based genomic screening
|
US20030211478A1
(en)
*
|
2002-05-08 |
2003-11-13 |
Gentel Corporation |
Transcription factor profiling on a solid surface
|
US20040009516A1
(en)
*
|
2002-05-08 |
2004-01-15 |
Nelson Bryce P. |
Arrayed SPR prism
|
US6878523B2
(en)
*
|
2002-05-08 |
2005-04-12 |
Gentel Bio Surfaces, Inc. |
Molecular interaction assays on a solid surface
|
US7351542B2
(en)
|
2002-05-20 |
2008-04-01 |
The Regents Of The University Of California |
Methods of modulating tubulin deacetylase activity
|
US20030228261A1
(en)
*
|
2002-06-05 |
2003-12-11 |
Aladar Szalay |
Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
|
EP1369491A1
(en)
|
2002-06-05 |
2003-12-10 |
Aladar A. Szalay |
Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
|
US7663022B1
(en)
|
2002-07-15 |
2010-02-16 |
Bruce Eric Hudkins |
Transgenic bioluminescent plants
|
AU2003261922A1
(en)
*
|
2002-09-06 |
2004-03-29 |
National Institute Of Advanced Industrial Science And Technology |
Secretory or membrane-binding chimeric protein
|
CA2499221A1
(en)
*
|
2002-09-16 |
2004-03-25 |
Promega Corporation |
Rapidly degraded reporter fusion proteins
|
US9453251B2
(en)
|
2002-10-08 |
2016-09-27 |
Pfenex Inc. |
Expression of mammalian proteins in Pseudomonas fluorescens
|
US6863731B2
(en)
*
|
2002-10-18 |
2005-03-08 |
Controls Corporation Of America |
System for deposition of inert barrier coating to increase corrosion resistance
|
US7951923B2
(en)
|
2002-11-12 |
2011-05-31 |
Zakrytoe Aktsionernoe Obschestvo ‘Evrogen’ |
Fluorescent proteins and chromoproteins from non-Aequorea hydrozoa species and methods for using same
|
US7413874B2
(en)
*
|
2002-12-09 |
2008-08-19 |
University Of Miami |
Nucleic acid encoding fluorescent proteins from aquatic species
|
ES2254044T3
(es)
*
|
2002-12-26 |
2010-12-30 |
ZAKRYTOE AKTSIONERNOE OBSCHESTVO " EVROGEN" |
Proteinas fluorescentes procedentes de especies de copepodos y procedimientos para usarlas.
|
US20050014932A1
(en)
|
2003-05-15 |
2005-01-20 |
Iogenetics, Llc |
Targeted biocides
|
US7173010B2
(en)
*
|
2003-05-19 |
2007-02-06 |
Regents Of The University Of Michigan |
Orphanin FQ receptor
|
WO2005019252A2
(en)
*
|
2003-05-22 |
2005-03-03 |
University Of Florida Research Foundation, Inc. |
Novel fluorescent and colored proteins, and polynucleotides that encode these proteins
|
ATE506456T1
(de)
|
2003-06-10 |
2011-05-15 |
David Gladstone Inst |
Verfahren zur behandlung von lentivirusinfektionen
|
CN100562570C
(zh)
|
2003-06-18 |
2009-11-25 |
吉恩勒克斯公司 |
修饰的重组痘苗病毒及其它微生物,及其应用
|
US7674291B2
(en)
|
2003-08-01 |
2010-03-09 |
Stratatech Corporation |
Human skin equivalents expressing exogenous polypeptides
|
US7330851B2
(en)
*
|
2003-08-18 |
2008-02-12 |
Eaglehawk, Limited |
Data security through dissembly of data elements or connections between elements
|
US8399618B2
(en)
|
2004-10-21 |
2013-03-19 |
Xencor, Inc. |
Immunoglobulin insertions, deletions, and substitutions
|
US8883147B2
(en)
|
2004-10-21 |
2014-11-11 |
Xencor, Inc. |
Immunoglobulins insertions, deletions, and substitutions
|
US20050221429A1
(en)
*
|
2004-01-16 |
2005-10-06 |
Cardinal Health Pts, Llc |
Host cells containing multiple integrating vectors comprising an amplifiable marker
|
US7432057B2
(en)
*
|
2004-01-30 |
2008-10-07 |
Michigan State University |
Genetic test for PSE-susceptible turkeys
|
US7481997B1
(en)
|
2004-02-12 |
2009-01-27 |
Montana State University |
Snow mountain virus genome sequence, virus-like particles and methods of use
|
WO2005100565A1
(ja)
*
|
2004-03-31 |
2005-10-27 |
Nec Soft Ltd. |
新規な蛍光性タンパク質とそれをコードする遺伝子
|
US7250298B2
(en)
|
2004-04-07 |
2007-07-31 |
The University Of Chicago |
Monomeric red fluorescent proteins
|
CA2574953A1
(en)
|
2004-07-26 |
2006-02-09 |
Dow Global Technolgies Inc. |
Process for improved protein expression by strain engineering
|
US20060040391A1
(en)
*
|
2004-08-20 |
2006-02-23 |
Promega Corporation |
RNA interference vectors
|
US7728118B2
(en)
*
|
2004-09-17 |
2010-06-01 |
Promega Corporation |
Synthetic nucleic acid molecule compositions and methods of preparation
|
US7786310B2
(en)
*
|
2004-11-05 |
2010-08-31 |
The Regents Of The University Of Michigan |
Small molecule transcriptional activation domains
|
KR101027427B1
(ko)
|
2004-11-12 |
2011-04-11 |
젠코어 인코포레이티드 |
FcRn에 대하여 증가된 결합력을 갖는 Fc 변이체
|
US8802820B2
(en)
|
2004-11-12 |
2014-08-12 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
US7230080B2
(en)
*
|
2005-02-16 |
2007-06-12 |
University Of Florida Research Foundation, Inc. |
Fluorescent and colored proteins, and polynucleotides that encode these proteins
|
EP1858333B1
(en)
|
2005-03-01 |
2015-12-23 |
Stratatech Corporation |
Human skin equivalents expressing exogenous polypeptides
|
JP2008532550A
(ja)
|
2005-03-17 |
2008-08-21 |
ストラタテック コーポレーション |
純度が改良された代用皮膚
|
US7794951B2
(en)
*
|
2005-10-18 |
2010-09-14 |
University Of Massachusetts Medical School |
SREBP2gc transcription factors and uses thereof
|
ATE516370T1
(de)
*
|
2005-12-22 |
2011-07-15 |
Sloan Kettering Inst Cancer |
Verfahren zur erfassung von krebszellen unter verwendung eines virus
|
CA2651423A1
(en)
*
|
2006-03-23 |
2007-10-04 |
The Regents Of The University Of Michigan |
Compositions and methods for generating transgenic animals
|
US20080004410A1
(en)
*
|
2006-06-30 |
2008-01-03 |
Yu-Chin Lai |
Hydrophilic macromonomers having alpha,beta-conjugated carboxylic terminal group and medical devices incorporating same
|
TW200819540A
(en)
|
2006-07-11 |
2008-05-01 |
Genelux Corp |
Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
|
US7977535B2
(en)
|
2006-07-12 |
2011-07-12 |
Board Of Trustees Of Michigan State University |
DNA encoding ring zinc-finger protein and the use of the DNA in vectors and bacteria and in plants
|
EP2450710B1
(en)
|
2006-07-14 |
2020-09-02 |
The Regents of The University of California |
Cancer biomarkers and methods of use thereof
|
US7833527B2
(en)
|
2006-10-02 |
2010-11-16 |
Amgen Inc. |
Methods of treating psoriasis using IL-17 Receptor A antibodies
|
CN101522899B
(zh)
|
2006-10-10 |
2012-07-25 |
百疗医株式会社 |
安全性改善的表达载体
|
US8052968B2
(en)
|
2006-10-16 |
2011-11-08 |
Genelux Corporation |
Modified vaccinia virus strains for use in diagnostic and therapeutic methods
|
US20090235373A1
(en)
*
|
2007-02-08 |
2009-09-17 |
The Regents Of The University Of Michigan |
Method of delivery of nucleic acids to a developing embryo
|
TW200836625A
(en)
|
2007-03-13 |
2008-09-16 |
Otsuka Pharma Co Ltd |
Evaluation method for tissue-preserving liquid
|
WO2008118445A1
(en)
*
|
2007-03-26 |
2008-10-02 |
Promega Corporation |
Methods to quench light from optical reactions
|
JP5444553B2
(ja)
|
2007-04-27 |
2014-03-19 |
フェネックス インコーポレイテッド |
微生物宿主を迅速にスクリーニングして、異種タンパク質発現の収率および/または質が改善されている特定の株を同定する方法
|
US9580719B2
(en)
|
2007-04-27 |
2017-02-28 |
Pfenex, Inc. |
Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
|
WO2008150496A2
(en)
*
|
2007-05-31 |
2008-12-11 |
Genelux Corporation |
Assay for sensitivity to chemotherapeutic agents
|
WO2009025847A2
(en)
|
2007-08-21 |
2009-02-26 |
Nodality, Inc. |
Methods for diagnosis, prognosis and methods of treatment
|
TWI595005B
(zh)
|
2007-08-21 |
2017-08-11 |
安健股份有限公司 |
人類c-fms抗原結合蛋白質
|
TW200918553A
(en)
|
2007-09-18 |
2009-05-01 |
Amgen Inc |
Human GM-CSF antigen binding proteins
|
SG10201606120XA
(en)
|
2007-10-02 |
2016-09-29 |
Theranos Inc |
Modular Point-Of-Care Devices And Uses Thereof
|
AU2008345242B2
(en)
|
2007-10-31 |
2014-02-27 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
US8679749B2
(en)
*
|
2007-11-01 |
2014-03-25 |
The University Of Chicago |
Red fluorescent proteins with enhanced bacterial expression, increased brightness and reduced aggregation
|
US8309306B2
(en)
|
2008-11-12 |
2012-11-13 |
Nodality, Inc. |
Detection composition
|
JO3382B1
(ar)
|
2008-12-23 |
2019-03-13 |
Amgen Inc |
أجسام مضادة ترتبط مع مستقبل cgrp بشري
|
US8242248B2
(en)
|
2009-03-23 |
2012-08-14 |
Nodality, Inc. |
Kits for multiparametric phospho analysis
|
WO2011011733A2
(en)
|
2009-07-24 |
2011-01-27 |
The Regents Of The University Of Michigan |
Factor replacement therapy
|
TW201117824A
(en)
|
2009-10-12 |
2011-06-01 |
Amgen Inc |
Use of IL-17 receptor a antigen binding proteins
|
UA109888C2
(uk)
|
2009-12-07 |
2015-10-26 |
|
ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
|
US20110262954A1
(en)
|
2010-03-18 |
2011-10-27 |
Universitat Regensburg |
Shuttle vector based transformation system for pyrococcus furiosus
|
WO2011130417A2
(en)
|
2010-04-15 |
2011-10-20 |
Amgen Inc. |
HUMAN FGF RECEPTOR AND β-KLOTHO BINDING PROTEINS
|
US20120003639A1
(en)
|
2010-04-27 |
2012-01-05 |
Prelude, Inc. |
Cancer biomarkers and methods of use thereof
|
EA024121B9
(ru)
|
2010-05-10 |
2017-01-30 |
Дзе Реджентс Ов Дзе Юниверсити Ов Калифорния |
Композиции эндорибонуклеаз и способы их использования
|
WO2012030738A2
(en)
|
2010-08-30 |
2012-03-08 |
Beckman Coulter, Inc. |
Complex phosphoprotein activation profiles
|
TWI639703B
(zh)
|
2011-01-21 |
2018-11-01 |
賽瑞諾斯有限公司 |
樣本使用最大化之系統及方法
|
US10227569B2
(en)
|
2011-04-12 |
2019-03-12 |
Emory University |
Respiratory syncytial virus expression vectors
|
ES2733211T3
(es)
|
2011-04-15 |
2019-11-28 |
Genelux Corp |
Cepas clonales de virus vaccinia atenuados y métodos de uso de las mismas
|
WO2012155071A1
(en)
|
2011-05-12 |
2012-11-15 |
Gilead Biologics, Inc. |
Methods of identifying lysyl oxidase - like - 2 (loxl2) binding partners
|
US9574002B2
(en)
|
2011-06-06 |
2017-02-21 |
Amgen Inc. |
Human antigen binding proteins that bind to a complex comprising β-Klotho and an FGF receptor
|
WO2012178136A2
(en)
|
2011-06-24 |
2012-12-27 |
University Of Houston System |
Fusion proteins of bacterial luciferase as multicolor luminescent sensors
|
WO2013016220A1
(en)
|
2011-07-22 |
2013-01-31 |
Amgen Inc. |
Il-17 receptor a is required for il-17c biology
|
US8475739B2
(en)
|
2011-09-25 |
2013-07-02 |
Theranos, Inc. |
Systems and methods for fluid handling
|
US9664702B2
(en)
|
2011-09-25 |
2017-05-30 |
Theranos, Inc. |
Fluid handling apparatus and configurations
|
US9619627B2
(en)
|
2011-09-25 |
2017-04-11 |
Theranos, Inc. |
Systems and methods for collecting and transmitting assay results
|
US8435738B2
(en)
|
2011-09-25 |
2013-05-07 |
Theranos, Inc. |
Systems and methods for multi-analysis
|
US9268915B2
(en)
|
2011-09-25 |
2016-02-23 |
Theranos, Inc. |
Systems and methods for diagnosis or treatment
|
US8840838B2
(en)
|
2011-09-25 |
2014-09-23 |
Theranos, Inc. |
Centrifuge configurations
|
US20140170735A1
(en)
|
2011-09-25 |
2014-06-19 |
Elizabeth A. Holmes |
Systems and methods for multi-analysis
|
US9632102B2
(en)
|
2011-09-25 |
2017-04-25 |
Theranos, Inc. |
Systems and methods for multi-purpose analysis
|
EP2758437B1
(en)
|
2011-09-22 |
2020-06-03 |
Amgen Inc. |
Cd27l antigen binding proteins
|
US9250229B2
(en)
|
2011-09-25 |
2016-02-02 |
Theranos, Inc. |
Systems and methods for multi-analysis
|
US10012664B2
(en)
|
2011-09-25 |
2018-07-03 |
Theranos Ip Company, Llc |
Systems and methods for fluid and component handling
|
US9810704B2
(en)
|
2013-02-18 |
2017-11-07 |
Theranos, Inc. |
Systems and methods for multi-analysis
|
WO2013052915A2
(en)
|
2011-10-05 |
2013-04-11 |
Genelux Corporation |
Method for detecting replication or colonization of a biological therapeutic
|
JP6635655B2
(ja)
|
2011-12-08 |
2020-01-29 |
アムジエン・インコーポレーテツド |
ヒトlcat抗原結合タンパク質および治療法におけるそれらの使用
|
CA2859364C
(en)
|
2011-12-16 |
2019-05-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Opsin polypeptides and methods of use thereof
|
AR091069A1
(es)
|
2012-05-18 |
2014-12-30 |
Amgen Inc |
Proteinas de union a antigeno dirigidas contra el receptor st2
|
JP6578206B2
(ja)
|
2012-07-19 |
2019-09-18 |
レッドウッド バイオサイエンス, インコーポレイテッド |
Cd22に特異的な抗体およびその使用方法
|
PL2885010T3
(pl)
|
2012-08-16 |
2020-11-16 |
Ipierian, Inc. |
Metody leczenia tauopatii
|
US9645151B2
(en)
|
2012-08-17 |
2017-05-09 |
California Institute Of Technology |
Targeting phosphofructokinase and its glycosylation form for cancer
|
US20140140959A1
(en)
|
2012-10-05 |
2014-05-22 |
Aladar A. Szalay |
Energy Absorbing-Based Diagnostic and Therapeutic Methods Employing Nucleic Acid Molecules Encoding Chromophore-Producing Enzymes
|
CA2889170C
(en)
|
2012-10-25 |
2021-09-07 |
True North Therapeutics, Inc. |
Anti-complement c1s antibodies and uses thereof
|
WO2014071206A1
(en)
|
2012-11-02 |
2014-05-08 |
True North Therapeutics, Inc. |
Anti-complement c1s antibodies and uses thereof
|
TW201425336A
(zh)
|
2012-12-07 |
2014-07-01 |
Amgen Inc |
Bcma抗原結合蛋白質
|
AU2014207618A1
(en)
|
2013-01-16 |
2015-08-06 |
Emory University |
Cas9-nucleic acid complexes and uses related thereto
|
US9920121B2
(en)
|
2013-01-25 |
2018-03-20 |
Amgen Inc. |
Antibodies targeting CDH19 for melanoma
|
JO3519B1
(ar)
|
2013-01-25 |
2020-07-05 |
Amgen Inc |
تركيبات أجسام مضادة لأجل cdh19 و cd3
|
US9783817B2
(en)
|
2013-03-04 |
2017-10-10 |
Arkansas State University |
Methods of expressing and detecting activity of expansin in plant cells
|
WO2014159764A1
(en)
|
2013-03-14 |
2014-10-02 |
Amgen Inc. |
Chrdl-1 antigen binding proteins and methods of treatment
|
US10232032B2
(en)
|
2013-03-14 |
2019-03-19 |
Emory University |
Recombinant RSV with silent mutations, vaccines, and methods related thereto
|
US9850297B2
(en)
|
2013-03-15 |
2017-12-26 |
Amgen Inc. |
Secreted frizzle-related protein 5 (SFRP5) binding proteins
|
PT2970449T
(pt)
|
2013-03-15 |
2019-11-06 |
Amgen Res Munich Gmbh |
Moléculas de ligação de cadeia única compreendendo abp n-terminal
|
WO2014140368A1
(en)
|
2013-03-15 |
2014-09-18 |
Amgen Research (Munich) Gmbh |
Antibody constructs for influenza m2 and cd3
|
JP6283408B2
(ja)
|
2013-03-15 |
2018-02-21 |
アムジェン インコーポレイテッド |
ヒトpac1抗体
|
CN118271441A
(zh)
|
2013-05-30 |
2024-07-02 |
基尼克萨制药有限公司 |
制瘤素m受体抗原结合蛋白
|
LT3007726T
(lt)
|
2013-06-10 |
2020-09-10 |
Ipierian, Inc. |
Tautopatijos gydymo būdai
|
US9770461B2
(en)
|
2013-08-02 |
2017-09-26 |
California Institute Of Technology |
Tailored glycopolymers as anticoagulant heparin mimetics
|
US10227370B2
(en)
|
2013-08-02 |
2019-03-12 |
California Institute Of Technology |
Heparan sulfate/heparin mimetics with anti-chemokine and anti-inflammatory activity
|
TW201605896A
(zh)
|
2013-08-30 |
2016-02-16 |
安美基股份有限公司 |
Gitr抗原結合蛋白
|
AR097648A1
(es)
|
2013-09-13 |
2016-04-06 |
Amgen Inc |
Combinación de factores epigenéticos y compuestos biespecíficos que tienen como diana cd33 y cd3 en el tratamiento de leucemia mieloide
|
MX2016006356A
(es)
|
2013-11-27 |
2016-10-28 |
Ipierian Inc |
Metodos de tratamiento de una tauopatia.
|
WO2015103438A2
(en)
|
2014-01-02 |
2015-07-09 |
Genelux Corporation |
Oncolytic virus adjunct therapy with agents that increase virus infectivity
|
US9714429B2
(en)
|
2014-01-28 |
2017-07-25 |
Arkansas State University |
Regulatory sequence of cupin family gene
|
RU2019119862A
(ru)
|
2014-02-20 |
2019-07-15 |
Аллерган, Инк. |
Антитела к компоненту комплемента c5
|
RU2673036C2
(ru)
|
2014-02-27 |
2018-11-21 |
Аллерган, Инк. |
АНТИТЕЛА К ФАКТОРУ КОМПЛЕМЕНТА Bb
|
AU2015295242B2
(en)
|
2014-07-31 |
2020-10-22 |
Amgen Research (Munich) Gmbh |
Bispecific single chain antibody construct with enhanced tissue distribution
|
AR101669A1
(es)
|
2014-07-31 |
2017-01-04 |
Amgen Res (Munich) Gmbh |
Constructos de anticuerpos para cdh19 y cd3
|
AU2015294834B2
(en)
|
2014-07-31 |
2021-04-29 |
Amgen Research (Munich) Gmbh |
Optimized cross-species specific bispecific single chain antibody constructs
|
JP6824594B2
(ja)
*
|
2014-09-11 |
2021-02-03 |
Jnc株式会社 |
合成遺伝子の設計方法
|
WO2016040767A2
(en)
|
2014-09-12 |
2016-03-17 |
Amgen Inc. |
Chrdl-1 epitopes and antibodies
|
EP3227687A4
(en)
|
2014-12-05 |
2018-10-24 |
Prelude, Inc. |
Dcis recurrence and invasive breast cancer
|
WO2016166360A1
(en)
|
2015-04-17 |
2016-10-20 |
Bayer Pharma Aktiengesellschaft |
Bispecific antibody constructs for cdh3 and cd3
|
WO2016189118A1
(en)
|
2015-05-28 |
2016-12-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods of prognosis and treatment of patients suffering from acute myeloid leukemia
|
TWI744242B
(zh)
|
2015-07-31 |
2021-11-01 |
德商安美基研究(慕尼黑)公司 |
Egfrviii及cd3抗體構築體
|
TWI793062B
(zh)
|
2015-07-31 |
2023-02-21 |
德商安美基研究(慕尼黑)公司 |
Dll3及cd3抗體構築體
|
TWI717375B
(zh)
|
2015-07-31 |
2021-02-01 |
德商安美基研究(慕尼黑)公司 |
Cd70及cd3抗體構築體
|
TWI796283B
(zh)
|
2015-07-31 |
2023-03-21 |
德商安美基研究(慕尼黑)公司 |
Msln及cd3抗體構築體
|
TWI829617B
(zh)
|
2015-07-31 |
2024-01-21 |
德商安美基研究(慕尼黑)公司 |
Flt3及cd3抗體構築體
|
IL257798B1
(en)
|
2015-09-02 |
2024-06-01 |
Immutep Sas |
Antibodies against LAG-3
|
KR20180085730A
(ko)
|
2015-10-29 |
2018-07-27 |
에모리 유니버시티 |
키메라 rsv, 면역원성 조성물, 및 사용 방법
|
IL296682A
(en)
|
2015-12-23 |
2022-11-01 |
Amgen Inc |
A method for treating or improving metabolic disorders using gastric inhibitory peptide receptor binding proteins in combination with glucagon-like peptide 1 agonists
|
TWI797073B
(zh)
|
2016-01-25 |
2023-04-01 |
德商安美基研究(慕尼黑)公司 |
包含雙特異性抗體建構物之醫藥組合物
|
EA039859B1
(ru)
|
2016-02-03 |
2022-03-21 |
Эмджен Рисерч (Мюник) Гмбх |
Биспецифические конструкты антител, связывающие egfrviii и cd3
|
IL260958B1
(en)
|
2016-02-03 |
2024-07-01 |
Amgen Res Munich Gmbh |
Constructs of bispecific antibodies to BCMA and CD3 that bind to T cells, preparations containing the same and uses thereof
|
LT3411404T
(lt)
|
2016-02-03 |
2022-12-27 |
Amgen Research (Munich) Gmbh |
Psma ir cd3 bispecifiniai, t ląsteles aktyvuojantys antikūno konstruktai
|
JOP20170091B1
(ar)
|
2016-04-19 |
2021-08-17 |
Amgen Res Munich Gmbh |
إعطاء تركيبة ثنائية النوعية ترتبط بـ cd33 وcd3 للاستخدام في طريقة لعلاج اللوكيميا النخاعية
|
EP3480320A4
(en)
|
2016-06-30 |
2020-03-11 |
Biois Co., Ltd. |
BICATENARY NUCLEIC ACID SIGNAL PROBE AND TARGET MOLECULE DETECTION METHOD USING THE SAME
|
JOP20190177A1
(ar)
|
2017-01-17 |
2019-07-16 |
Amgen Inc |
طريقة لعلاج أو تحسين اضطرابات أيضية باستخدام مساعدات مستقبل glp-1 مقترنة بمناهضات لمستقبل ببتيد مثبط معوي (gipr)
|
JOP20190189A1
(ar)
|
2017-02-02 |
2019-08-01 |
Amgen Res Munich Gmbh |
تركيبة صيدلانية ذات درجة حموضة منخفضة تتضمن بنيات جسم مضاد يستهدف الخلية t
|
CA3053906A1
(en)
|
2017-02-16 |
2018-08-23 |
Sonnet BioTherapeutics, Inc. |
Albumin binding domain fusion proteins
|
WO2018204907A1
(en)
|
2017-05-05 |
2018-11-08 |
Amgen Inc. |
Pharmaceutical composition comprising bispecific antibody constructs for improved storage and administration
|
JOP20190259A1
(ar)
|
2017-05-31 |
2019-10-31 |
Amgen Inc |
بروتينات ربط مولد ضد مضادة لـ jagged1
|
UY37753A
(es)
|
2017-06-02 |
2018-11-30 |
Amgen Inc |
Antagonistas de péptido pac1
|
CN110831969B
(zh)
|
2017-06-20 |
2024-06-21 |
安进公司 |
使用抑胃肽受体(gipr)结合蛋白与glp-1激动剂的组合治疗或改善代谢障碍的方法
|
US10851350B1
(en)
|
2017-06-27 |
2020-12-01 |
Genelux Corporation |
Bioreactor production of virus from adherent cells
|
WO2019028382A1
(en)
|
2017-08-04 |
2019-02-07 |
Amgen Inc. |
CYS-MABS CONJUGATION METHOD
|
JP7344206B2
(ja)
|
2017-12-11 |
2023-09-13 |
アムジェン インコーポレイテッド |
二重特異性抗体製品のための連続製造プロセス
|
UY38041A
(es)
|
2017-12-29 |
2019-06-28 |
Amgen Inc |
Construcción de anticuerpo biespecífico dirigida a muc17 y cd3
|
EP3830121A1
(en)
|
2018-07-30 |
2021-06-09 |
Amgen Research (Munich) GmbH |
Prolonged administration of a bispecific antibody construct binding to cd33 and cd3
|
UY38326A
(es)
|
2018-08-03 |
2020-01-31 |
Amgen Inc |
Constructos de anticuerpos para cldn18.2 y cd3
|
JP2022500504A
(ja)
|
2018-09-14 |
2022-01-04 |
プレリュード コーポレーションPrelude Corporation |
浸潤性乳癌のリスクを有する対象の治療の選択方法
|
KR20210068408A
(ko)
|
2018-09-28 |
2021-06-09 |
암젠 인크 |
가용성 bcma에 대한 항체
|
AU2019356564A1
(en)
|
2018-10-11 |
2021-04-29 |
Amgen Inc. |
Downstream processing of bispecific antibody constructs
|
US20220025058A1
(en)
|
2018-11-06 |
2022-01-27 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the treatment of acute myeloid leukemia by eradicating leukemic stem cells
|
AU2020205073A1
(en)
|
2019-01-03 |
2021-08-19 |
Invetx Inc. |
Compositions for increasing half-life of a therapeutic agent in canines and methods of use
|
CN111662921B
(zh)
*
|
2019-02-21 |
2022-10-14 |
中国科学院微生物研究所 |
一种示踪棉花细胞中微管正极端的转基因棉花标签株系的培育方法及其应用
|
US20220259547A1
(en)
|
2019-06-13 |
2022-08-18 |
Amgeng Inc. |
Automated biomass-based perfusion control in the manufacturing of biologics
|
CN110511281B
(zh)
*
|
2019-08-19 |
2022-05-17 |
中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) |
一种具有红色荧光活性的检测蛋白的日本血吸虫抗体检测试剂盒
|
CN110437341B
(zh)
*
|
2019-08-19 |
2022-05-17 |
中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) |
一种具有红色荧光活性的检测蛋白及其应用
|
CN110511283B
(zh)
*
|
2019-08-26 |
2022-05-17 |
中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) |
一种具有绿色荧光活性的检测蛋白的检测试剂盒
|
AU2020345787A1
(en)
|
2019-09-10 |
2022-03-24 |
Amgen Inc. |
Purification method for bispecific antigen-binding polypeptides with enhanced protein L capture dynamic binding capacity
|
AU2020381536A1
(en)
|
2019-11-13 |
2022-04-21 |
Amgen Inc. |
Method for reduced aggregate formation in downstream processing of bispecific antigen-binding molecules
|
WO2021150824A1
(en)
|
2020-01-22 |
2021-07-29 |
Amgen Research (Munich) Gmbh |
Combinations of antibody constructs and inhibitors of cytokine release syndrome and uses thereof
|
CN115427454A
(zh)
|
2020-03-19 |
2022-12-02 |
安进公司 |
针对粘蛋白17的抗体及其用途
|
CA3178123A1
(en)
|
2020-05-11 |
2021-11-18 |
William Brondyk |
Compositions for increasing half-life of a therapeutic agent in canines and methods of use
|
CA3183756A1
(en)
|
2020-05-19 |
2021-11-25 |
Amgen Inc. |
Mageb2 binding constructs
|
JP2023527972A
(ja)
|
2020-05-29 |
2023-07-03 |
アムジエン・インコーポレーテツド |
Cd33及びcd3に結合する二重特異性コンストラクトの有害作用軽減投与
|
WO2022008488A1
(en)
|
2020-07-06 |
2022-01-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of slamf1 as a biomarker in colorectal cancer
|
MX2023000500A
(es)
|
2020-07-10 |
2023-04-12 |
Invetx Inc |
Composiciones para aumentar la semivida de un agente terapeutico en felinos y modos de uso.
|
WO2022013256A1
(en)
|
2020-07-15 |
2022-01-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of cd160 as a biomarker in acute myeloid leukemia
|
CN116529382A
(zh)
|
2020-10-02 |
2023-08-01 |
吉恩勒克斯公司 |
由贴壁细胞在生物反应器中产生病毒
|
EP4240767A1
(en)
|
2020-11-06 |
2023-09-13 |
Amgen Inc. |
Polypeptide constructs binding to cd3
|
TW202233678A
(zh)
|
2020-11-06 |
2022-09-01 |
德商安美基研究(慕尼黑)公司 |
具有增強的剪切特徵的多肽
|
AU2021374839A1
(en)
|
2020-11-06 |
2023-06-08 |
Amgen Inc. |
Multitargeting bispecific antigen-binding molecules of increased selectivity
|
BR112023008629A2
(pt)
|
2020-11-06 |
2023-10-03 |
Amgen Inc |
Construtos de polipeptídeos que se ligam seletivamente a cldn6 e cd3
|
WO2022159520A2
(en)
|
2021-01-20 |
2022-07-28 |
Nautilus Biotechnology, Inc. |
Systems and methods for biomolecule quantitation
|
AU2022246675A1
(en)
|
2021-04-02 |
2023-10-19 |
Amgen Inc. |
Mageb2 binding constructs
|
AU2022269312A1
(en)
|
2021-05-06 |
2023-10-19 |
Amgen Research (Munich) Gmbh |
Cd20 and cd22 targeting antigen-binding molecules for use in proliferative diseases
|
CN113584062B
(zh)
*
|
2021-08-02 |
2022-03-11 |
中国人民解放军军事科学院军事医学研究院 |
融合成像基因及其慢病毒表达质粒、慢病毒、细胞,其制备方法和用途
|
TW202346368A
(zh)
|
2022-05-12 |
2023-12-01 |
德商安美基研究(慕尼黑)公司 |
具有增加的選擇性的多鏈多靶向性雙特異性抗原結合分子
|
WO2024059675A2
(en)
|
2022-09-14 |
2024-03-21 |
Amgen Inc. |
Bispecific molecule stabilizing composition
|
WO2024104551A1
(en)
|
2022-11-14 |
2024-05-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of the population of slamf4+ ccr5+ effector memory cd4+ t cells as a biomarker in rheumatoid arthritis
|
WO2024145280A2
(en)
|
2022-12-27 |
2024-07-04 |
Invetx, Inc. |
Polypeptides with altered binding to neonatal fc receptor (fcrn) and methods of use
|
US20240209096A1
(en)
|
2022-12-27 |
2024-06-27 |
Invetx, Inc. |
Polypeptides with altered binding to neonatal fc receptor (fcrn) and methods of use
|
CN116297415B
(zh)
*
|
2023-05-11 |
2023-08-18 |
细胞生态海河实验室 |
一种protac药物的筛选方法及载体
|